The multiplex procedure has been adapted to quantitative detection of 7 common mutations of KRAS (in codons 12 and 13) in plasma samples and primary tumor samples from patients with metastatic colorectal cancer (mCRC) (Taly et al., 2013, Laurent-Puig et al., 2015). This evidence concerns the gene KRAS and neoplasm.